Personal Information
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
www.merckmillipore.com
Acerca de
Not intended for US & CA visitors.
Merck Life Sciences is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of Life Science. Merck Millipore is known as EMD Millipore in the U.S. and Canada.
Etiquetas
merck
milliporesigma
formulation
regulatory
bioprocessing
next generation bioprocessing
biopharmaceutical manufacturing
single-use
downstream processing
biopharmaceuticals
process development- biomanufacturing
tangential flow filtration
continuous bioprocessing
gene therapy
monoclonal antibody
cell culture media
cell culture
clarification
webinar
biosafety
bioreactor
cell line development
chromatography
upstream processing
cell & gene therapy
biomanufacturing
final fill
pharmaceutical
sterile filtration
regulatory guidelines
biosafety testing
solid formulation
purification
viral clearance
single-use systems
excipients
process intensification
risk assessment
bioreliance
next generation processing
clarification/harvest
contract dev & mfg
antibody drug conjugate
vaccine manufacturing
mabs
vaccines
risk mitigation
cell therapies
process mabs
diafiltration
active pharmaceutical ingredient
viral safety
regulatory requirements
virus removal
patient safety
adcs
harvest
ultrafiltration
ultrafiltration/diafiltration & concentration
cell and gene therapy
biosafety services
aav
adeno-associated viruses (aav)
sterilization
chromatography purification
drug development
viral contamination
buffer & media prep
adeno-associated virus
adc
sterile sampling
product characterization
raw materials
case study
viral vector manufacturing
virus detection
biologics safety
chozn
chromatography resins
viscosity reducing excipients
mrna vaccines
healthcare
conjugation
cell therapy
mab
e2e
api
chemistry
tff
manufacturing
extractables and leachables
scale up
cell line
virus
viral vector
perfusion
vaccine processing
pharmacetuical process development
large scale cell culture
viscosity reducing agents
viscosity reducing additives
protein viscosity
iv to subq
iv to sc
intravenous to subcutaneous
intradermal injection
high concentration protein formulations
biotherapeutic formulation
sterile filtration & bioburden control
validation
research
continuous manufacturing
monoclonal antibodies
upstream process
solubility enhancement
single use
bioprocess development
sptff
collaboration
plasma
education and training
training
lentivirus
novel therapies
risk management
sterilizing grade filters
biotechnology
seed train
cell culture seed train
adventitious virus contamination
process validation
bioburden
qbd
tech transfer
cmo
chozn gs-/- expression system
next-gen processing
perfusion media
contract manufacturing
biosimilars
therapeutic protein formulations
reformulating protein biotherapeutics
subcutaneous formulation development
intravenous injection
intramuscular injection
viscosity reduction platform
regulatory/validation
bioburden control
single-pass tff
downstream
mrna
quality by design
protein stability
automation
solid dose
virus inactivation
downstream purification
single-use technology
pupsit
covid-19
drug delivery
fluid management
chromatography/purification
api synthesis
sterilizing filtration
host cell protein
gene therapy manufacturing
regulatory affairs / validation
single-use bioreactors
amorphous formulation
cell line characterization
filtration
innovation
aseptic filter
life science
continuous processing
bioavailability
liquid formulation
usp <665>
vlp
clinical development
molecule
toxicology
cell bank
extractables
bpog
virus prevention
cgmp
pharma
stem cells
human mesenchymal stromal
operator safety
protein purification
protein aggregation
automation system
a&f
viscosity reducing excipient
protein viscosity on syringeability
innovative technologies in biomolecule formulation
adc therapies
chetosensartm
maycoretm
dolcoretm
josephine cheng
bacterial fermentation
cld
gmp-compliant
mab development
aav therapy
emprove® api
chemical synthesis
solid dosage
replication competent virus
3d printing technology
3d printing
pdadmac
data visualization & analysis
concentration
mrna manufacturing process
cation exchange chromatography
tupps
nanoparticulate impurities
recombinant protein
biologics
pdna
plasmid dna
bioprocess orchestration software
final sterile filtration
anion exchange chromatography
depth filtration
flow-through polishing
microfiltration
integrity testing
bioburden reduction
normal flow filtration
advanced drug delivery
drug release
pva
vgt
lipid based rna
car-t
facility of the future
excipient risk assessment
ccm
process development
active and formulation
buffer
biocontinuum
dsp platform
viral & gene (vgt) therapy manufacturing
sterile filtration / prefiltration
draft annex 1
excipient
provantage biodevt & e2e services
mesoporous silica technology
mesoporous silica formulations
mesoporous silica
lot release testing
activated pegs
peg
membrane chromatography
natrix
pcr
cho
supply chain
viral therapies
gene editing
mass spectrometry
filter
polyvinyl alcohol
hot melt extrusion
semi-solid formulation
emprove
solid dosage drug formulation
api stability
upstream and downstream processing
lipid nanoparticles
lipids
zika
mscs
protein a membrane
chromatpgraphy
in vitro
regulatory documentation
viral product manufacturing
filter integrity testing
emerging biotech
biotech process
ich q10
hmscs
virus safety
continuous process
stainless steel
clean rooms
biologic drugs
tablet coating polyvinyl
tablet coating
tio2 alternative
titanium dioxide alternative
tio2
titanium dioxide
calcium carbonate
parteck ta
resin performance
increase lifetime
cleaning efficiency
protein a column
eshmuno a
eshmuno
naoh
cleaning in place
cip
ethylene glycol
cation exchange
protein a
excipient impact
protein stabilization
particle formation
agitation stress
protein solutions
surfactants
api processing
cocrystal formation
salt formation
api solubility
spike protein
sars-cov-2
sac
equipment qualification
cdc
adcc
actives and dormulation
regulatory expectations
biophorum
pharma raw material risk
leachables risk assessment
extractables risk assessment
pharmaceutical risk management
filtration technology
extractables data
remote technology
remote audit
remote
virtual technology
technology
audits
audit
qc testing
gmp
gene therapies
therapeutic medicine
ngs
ngs assays
viral gene therapy
identity testing
large scale manufacturing
melt based 3d
melt based
polymers
3d
t cell
ekko™ select system
dmso
car-t manufacturing
acoustic cell processing syste
ekko™
ich q5a
q5a
virus testing
process automation
process orchestration
operational efficiency
product quality
process orchestrator
bioprocess orchestration softw
bio4c
west african pandemic
technovax
innovative biotech
sars-cov-2 vaccine
cov-2 vaccines
vaccine collaboration
virus like particle
x-ray
x-ray sterilization
adenoviral vectors
rca testing
rca assay
rca
high intensity sweeteners
sucralose
neotame
types of oral solid dosage forms
types of oral dosage form
tablets dosage forms
solid pharmaceutical dosage form
solid dose pharmaceuticals
solid dosage formulation
solid dosage forms include
solid dosage forms
pharmaceutical solid dosage forms
oral solid dosage manufacturing
oral solid dosage forms
oral solid dosage
oral solid
oral dosage forms
formulation of tablet dosage form
dosage form of tablet
adc express™
hydrophilicity
adc payloads
adcore product line
small scale
risk of cross-contamination
sterile medicinal products
biopharmaceutical
eu gmp annex 1 draft
bevs
performant rhabdovirus-free
sf9 rhabdovirus-negative
sf-rvn
baculovirus expression vector
complex injectables
viscous formulations
nanoparticles
liposomes
microbial ingress
helium integrity test
helium
lysis
viral vector therapy
subhasis banerjee
somasundaram g
liquid dosage form
lipopolysaccharide
fine chemicals
endotoxin removal
endotoxin control and clearance
endotoxin contamination
contamination control strategy
pva in ophthalmics
ophthalmic formulation
ophthalmics
ophthalmic excipients
excipient flowability
dust formation of chemicals
reduced caking excipients
free flowing excipients
pharma manufacturing efficiency
dry granulated excipients
roller compaction raw materials
compacted excipients
granulated pharmaceutical raw materials
viral clearance studies
virus bank services
virus filters
recombinant production
recombinant development
mab production
paul genest
filter performance
filter virus removal
optimize filter virus removal
filter capacity
parvovirus filtration
product safety
stability testing
edmund ang
janice tan
chozn expression platform
cd cloning media
subsequent bioprocess
chemistry manufacturing controls
cmc
chemically defined cloning media
production cell line
upstream process develoment
dolastin
giuseppe camporeale
ashok kumar
payload intermediate
linker-payload
speed up
high-potent payloads
leo ohrem
solid dose formulation
xiaolong sun
jerome dalin
trends in vaccine manufacturing
quality management systems qmss
pharma grade sugar
excipient(s)
polyol(s)
low npi sucrose
bulking agent biomolecules
pharma(ceutical) grade sucrose
sucrose pharmaceutical excipient
stabilize biomolecules
syringability
subcutaneous administration
subq
reduce viscosity
synergistic effects
formation
thierry burnouf
subcutaneous igg infusion
scalable plasma process
aseptic filtration
removal of detergent
removal of solvent
virus inactivation steps
affinity chromatography
flow-through-mode chromatography
fractionation flow
safety and quality of plasma igg
plasma immunoglobulin purification
plasma igg
purification process
flow-through purification
fc-fusion
fc-fusion protein
chozn-gs system
chozn gs
chozn-gs
bacterial retention testing
validation services
eu gmp annex 1
vaccine technologies
vaccine development and manufacturing
vaccine development
novel vaccine development
human therapy
stemline®
bone marrow
ex vivo cell expansion
media formulation
human mesenchymal stromal/stem cells
mesenchymal stem cell growth
mesenchymal
xeno free culture
high yields
e&l
process validation strategy
regulatory considerations
risk-based approach
technology transfer
cdmo
end to end
capsid protein
cqa
critical quality attributes
orthogonal method
orthogonal methods
technically unavoidable particle profiles
emprove® chemicals
emprove®
lsm
laser scanning microscopy
optical coherence technology
coating formulation development
oct
particle designed pva
coating process
coating
dashboard
data center
saas
software and automation
software development
software
closed processing
single-use tff
hc agnostic
hcp id
hcp
host cell protein impurities
biotherapy purity
host cell proteins
powder feeding
cm
electrostatic charge
crazy powder
(qc) test methods
mycoplasma
methods for sterility
quality control testing
test methods
compen-dial
proteins
peptides
injectables
sterility assurance
roller compaction
granulated material
raw material handling
dry granulation
caking and clumping
manufacturing efficiency
flocculation
protein a resin
scale-up development
virusexpress™ lentiviral production platform
mobius® single-use bioreactors
templated manufacturing process
suspension-based lentivirus production
bioreactor process
scalable upstream bioreactor process
scalability
lentiviral vector production
filament-based
hot melt extrusion process
pharmaceutical industry
pharmaceutical manufacturing
pharmaceutical dosage
pharmaceutical dosage forms
additive manufacturing
formulation development
perfusion technologies
perfusate
viral contaminant
cell banks
bio4c™ processpad data management software
biocontinuum™
bioprocess lifecycle management
process verification (cpv)
bio4c™ processpad
advanced analytics
smart data management
bio4c™
chromatography resin
monoclonal antibody purification
preparative chromatography
analytical chromatography
oxygen mass transfer
clinical scale
bench scale
bioreactors
high-viscosity tff
reverse osmosis
nanofiltration
fed-batch production
fda regulatory guidance
rcl testing
lentivirus testing
biosafety and characterization testing
upstream
foot and mouth (fmd) disease
biopharma
media filtration
barrier filters
mrna therapies
mrna production process
mrna delivery systems
therapeutics
single-use manufaturing
e. coli
recombinant growth factor
antibody drug conjugates
technically unavoidable particles
chemicals
pharmaceuticals
coriolis
recombinant
npi
pharmaceutical-grade sucrose
intein
affinity capture
discovery
continuous virus inactivation
intensified capture
next-generation bioprocessing
filter plugging
bulk filtration
downstream unit operations
scalable purification
data driven
biopharma manufacturing
compressibility
bulk density
flow
continuous tablet manufacturing
microbial contamination
excipients in china
excipient regulations
biosolve
cost of goods sold
process model
viral vectors
sars-cov2
mers
ebola
h1n1 influenza
corona virus
outbreak
global health challenges
pandemic
vaccine production
fouling model
vmax method
pmax method
bpsa
perfusion bioreactor
single-pass tangential flow filtration
sedimentation velocity analytical ultracentrifugat
virus assay
cell assay
virology
viral genome
viral capsids
auc assay
tableting
sustained release
active pharmaceutical ingredients
fast track approach
• data visualization
• cpv
• continued process verification
• laboratory information management system (lims)
• manufacturing execution system (mes)
• enterprise resource planning (erp)
• biopharmaceutical processes
• data management
• next-generation bioprocessing
• software analytics
• software and automation
• integrated solutions
hdx mass spectrometry
peg linkers
spectroscopy
product recovery
acoustic cell processing
cell therapy manufacturing
blazar
viral screening
bioinformatics
next generation sequencing
rapid molecular method
biologic therapy
biotherapeutic
lai
long-acting injectable
targeted drug delivery
rna vaccines
rna therapeutics
rna delivery
novel cell models
immunotherapy research
immunotherapy
immunotherapeutics
genome editing technology
generating tumor-associated antigen panels
engineered custom cell line
engineered cell line
antigen cell lines
batch release
closed sampling
perfused seed train
integrated systems
perfusion filter
n-1
novel perfusion
cryopreservation
analytical development
titer
mitigating risks
big data
facility intensification
buffer delivery
process monitoring
regulatory compliant
continued process verification
cpv
purification template
horizon2020
disposable technology
continuous chromatography
biosimilar mab
virus spiking
api registration
formula
single-use connectors
single-use assemblies
integrity testers
cell & gene therapy (cgt) services
biopharm ingredients
biologics manufacturing
post approval changes
process impurities
assays
biotherapy
pei
eu commision
falsified medicine directive
chinese regulation
regulations
intensified mab purification
preclinical stage
clone selection
biopharma training
apac
emerging markets
efficiency in media preparation
compaction of cell culture media and single chemic
buffer concentrates
footprint saving buffer management
cell lines
cell culture media and supplements
industry 4.0
multi-use systems hardware
platform assay
platform manufacturing
solubility
slc
scale-up
gmp cell banking
activated polyethylene glycols
polyethylene glycols
liphophilic payload
pk/pd
monodisperse
linkers
clinical trial
kla
process scalability
bioprocess international
map/hap
supply robustness
forecast
collaborative forecasting
phenylketonuria
gmp manufacturing
glycosylation
n-glycan profiling of monoclonal antibodies
potency
single-pass tengential flow filtration
single-pass
prefilter
bioprocesing
intravenous immunoglobulin
ivig purification
process optimization
drug approval
accelerate product certification
pasteurization
viral risk mitigation
htst
small molecule series
smallmoleculeseries
pla/plga polymersmall molecules
optimum polymer technologyformulation technologies
synbiosys® multi-block polymer introductionparente
polymer based drug delivery systems
polymer based parenteral controlled-release drug d
biodevelopment
synthetic lipids
testing considerations
microcarrier
philipp buehle
2d data matrix barcode
2d barcode
barcode
drug manufacturer
raw materials supplier
digital innovation
biotech
events
science
douglas bowman
appropriate quality
bioreliance services
martin wisher
european pharmacopoeia
fda
agent contamination
virus seed
business development
zfn
risk
solvent
funding
corporate funding
startup
venture capital
alison armstrong
final fill vial
viral contamincation
viral risk
process sampling
novaseptum
genotoxicity
serum free media
fetal bovine serum
bioassays
small-molecule api
drypour
mobius
adventitious virus
ex-cell advanced
ucoe
expression vectors
shear protection
bioprocess performance loss
lot-to-lot variation
poloxamer 188
pluronic-f68
media prep
Ver más
Presentaciones
(187)Documentos
(23)Infografías
(1)Personal Information
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
www.merckmillipore.com
Acerca de
Not intended for US & CA visitors.
Merck Life Sciences is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of Life Science. Merck Millipore is known as EMD Millipore in the U.S. and Canada.
Etiquetas
merck
milliporesigma
formulation
regulatory
bioprocessing
next generation bioprocessing
biopharmaceutical manufacturing
single-use
downstream processing
biopharmaceuticals
process development- biomanufacturing
tangential flow filtration
continuous bioprocessing
gene therapy
monoclonal antibody
cell culture media
cell culture
clarification
webinar
biosafety
bioreactor
cell line development
chromatography
upstream processing
cell & gene therapy
biomanufacturing
final fill
pharmaceutical
sterile filtration
regulatory guidelines
biosafety testing
solid formulation
purification
viral clearance
single-use systems
excipients
process intensification
risk assessment
bioreliance
next generation processing
clarification/harvest
contract dev & mfg
antibody drug conjugate
vaccine manufacturing
mabs
vaccines
risk mitigation
cell therapies
process mabs
diafiltration
active pharmaceutical ingredient
viral safety
regulatory requirements
virus removal
patient safety
adcs
harvest
ultrafiltration
ultrafiltration/diafiltration & concentration
cell and gene therapy
biosafety services
aav
adeno-associated viruses (aav)
sterilization
chromatography purification
drug development
viral contamination
buffer & media prep
adeno-associated virus
adc
sterile sampling
product characterization
raw materials
case study
viral vector manufacturing
virus detection
biologics safety
chozn
chromatography resins
viscosity reducing excipients
mrna vaccines
healthcare
conjugation
cell therapy
mab
e2e
api
chemistry
tff
manufacturing
extractables and leachables
scale up
cell line
virus
viral vector
perfusion
vaccine processing
pharmacetuical process development
large scale cell culture
viscosity reducing agents
viscosity reducing additives
protein viscosity
iv to subq
iv to sc
intravenous to subcutaneous
intradermal injection
high concentration protein formulations
biotherapeutic formulation
sterile filtration & bioburden control
validation
research
continuous manufacturing
monoclonal antibodies
upstream process
solubility enhancement
single use
bioprocess development
sptff
collaboration
plasma
education and training
training
lentivirus
novel therapies
risk management
sterilizing grade filters
biotechnology
seed train
cell culture seed train
adventitious virus contamination
process validation
bioburden
qbd
tech transfer
cmo
chozn gs-/- expression system
next-gen processing
perfusion media
contract manufacturing
biosimilars
therapeutic protein formulations
reformulating protein biotherapeutics
subcutaneous formulation development
intravenous injection
intramuscular injection
viscosity reduction platform
regulatory/validation
bioburden control
single-pass tff
downstream
mrna
quality by design
protein stability
automation
solid dose
virus inactivation
downstream purification
single-use technology
pupsit
covid-19
drug delivery
fluid management
chromatography/purification
api synthesis
sterilizing filtration
host cell protein
gene therapy manufacturing
regulatory affairs / validation
single-use bioreactors
amorphous formulation
cell line characterization
filtration
innovation
aseptic filter
life science
continuous processing
bioavailability
liquid formulation
usp <665>
vlp
clinical development
molecule
toxicology
cell bank
extractables
bpog
virus prevention
cgmp
pharma
stem cells
human mesenchymal stromal
operator safety
protein purification
protein aggregation
automation system
a&f
viscosity reducing excipient
protein viscosity on syringeability
innovative technologies in biomolecule formulation
adc therapies
chetosensartm
maycoretm
dolcoretm
josephine cheng
bacterial fermentation
cld
gmp-compliant
mab development
aav therapy
emprove® api
chemical synthesis
solid dosage
replication competent virus
3d printing technology
3d printing
pdadmac
data visualization & analysis
concentration
mrna manufacturing process
cation exchange chromatography
tupps
nanoparticulate impurities
recombinant protein
biologics
pdna
plasmid dna
bioprocess orchestration software
final sterile filtration
anion exchange chromatography
depth filtration
flow-through polishing
microfiltration
integrity testing
bioburden reduction
normal flow filtration
advanced drug delivery
drug release
pva
vgt
lipid based rna
car-t
facility of the future
excipient risk assessment
ccm
process development
active and formulation
buffer
biocontinuum
dsp platform
viral & gene (vgt) therapy manufacturing
sterile filtration / prefiltration
draft annex 1
excipient
provantage biodevt & e2e services
mesoporous silica technology
mesoporous silica formulations
mesoporous silica
lot release testing
activated pegs
peg
membrane chromatography
natrix
pcr
cho
supply chain
viral therapies
gene editing
mass spectrometry
filter
polyvinyl alcohol
hot melt extrusion
semi-solid formulation
emprove
solid dosage drug formulation
api stability
upstream and downstream processing
lipid nanoparticles
lipids
zika
mscs
protein a membrane
chromatpgraphy
in vitro
regulatory documentation
viral product manufacturing
filter integrity testing
emerging biotech
biotech process
ich q10
hmscs
virus safety
continuous process
stainless steel
clean rooms
biologic drugs
tablet coating polyvinyl
tablet coating
tio2 alternative
titanium dioxide alternative
tio2
titanium dioxide
calcium carbonate
parteck ta
resin performance
increase lifetime
cleaning efficiency
protein a column
eshmuno a
eshmuno
naoh
cleaning in place
cip
ethylene glycol
cation exchange
protein a
excipient impact
protein stabilization
particle formation
agitation stress
protein solutions
surfactants
api processing
cocrystal formation
salt formation
api solubility
spike protein
sars-cov-2
sac
equipment qualification
cdc
adcc
actives and dormulation
regulatory expectations
biophorum
pharma raw material risk
leachables risk assessment
extractables risk assessment
pharmaceutical risk management
filtration technology
extractables data
remote technology
remote audit
remote
virtual technology
technology
audits
audit
qc testing
gmp
gene therapies
therapeutic medicine
ngs
ngs assays
viral gene therapy
identity testing
large scale manufacturing
melt based 3d
melt based
polymers
3d
t cell
ekko™ select system
dmso
car-t manufacturing
acoustic cell processing syste
ekko™
ich q5a
q5a
virus testing
process automation
process orchestration
operational efficiency
product quality
process orchestrator
bioprocess orchestration softw
bio4c
west african pandemic
technovax
innovative biotech
sars-cov-2 vaccine
cov-2 vaccines
vaccine collaboration
virus like particle
x-ray
x-ray sterilization
adenoviral vectors
rca testing
rca assay
rca
high intensity sweeteners
sucralose
neotame
types of oral solid dosage forms
types of oral dosage form
tablets dosage forms
solid pharmaceutical dosage form
solid dose pharmaceuticals
solid dosage formulation
solid dosage forms include
solid dosage forms
pharmaceutical solid dosage forms
oral solid dosage manufacturing
oral solid dosage forms
oral solid dosage
oral solid
oral dosage forms
formulation of tablet dosage form
dosage form of tablet
adc express™
hydrophilicity
adc payloads
adcore product line
small scale
risk of cross-contamination
sterile medicinal products
biopharmaceutical
eu gmp annex 1 draft
bevs
performant rhabdovirus-free
sf9 rhabdovirus-negative
sf-rvn
baculovirus expression vector
complex injectables
viscous formulations
nanoparticles
liposomes
microbial ingress
helium integrity test
helium
lysis
viral vector therapy
subhasis banerjee
somasundaram g
liquid dosage form
lipopolysaccharide
fine chemicals
endotoxin removal
endotoxin control and clearance
endotoxin contamination
contamination control strategy
pva in ophthalmics
ophthalmic formulation
ophthalmics
ophthalmic excipients
excipient flowability
dust formation of chemicals
reduced caking excipients
free flowing excipients
pharma manufacturing efficiency
dry granulated excipients
roller compaction raw materials
compacted excipients
granulated pharmaceutical raw materials
viral clearance studies
virus bank services
virus filters
recombinant production
recombinant development
mab production
paul genest
filter performance
filter virus removal
optimize filter virus removal
filter capacity
parvovirus filtration
product safety
stability testing
edmund ang
janice tan
chozn expression platform
cd cloning media
subsequent bioprocess
chemistry manufacturing controls
cmc
chemically defined cloning media
production cell line
upstream process develoment
dolastin
giuseppe camporeale
ashok kumar
payload intermediate
linker-payload
speed up
high-potent payloads
leo ohrem
solid dose formulation
xiaolong sun
jerome dalin
trends in vaccine manufacturing
quality management systems qmss
pharma grade sugar
excipient(s)
polyol(s)
low npi sucrose
bulking agent biomolecules
pharma(ceutical) grade sucrose
sucrose pharmaceutical excipient
stabilize biomolecules
syringability
subcutaneous administration
subq
reduce viscosity
synergistic effects
formation
thierry burnouf
subcutaneous igg infusion
scalable plasma process
aseptic filtration
removal of detergent
removal of solvent
virus inactivation steps
affinity chromatography
flow-through-mode chromatography
fractionation flow
safety and quality of plasma igg
plasma immunoglobulin purification
plasma igg
purification process
flow-through purification
fc-fusion
fc-fusion protein
chozn-gs system
chozn gs
chozn-gs
bacterial retention testing
validation services
eu gmp annex 1
vaccine technologies
vaccine development and manufacturing
vaccine development
novel vaccine development
human therapy
stemline®
bone marrow
ex vivo cell expansion
media formulation
human mesenchymal stromal/stem cells
mesenchymal stem cell growth
mesenchymal
xeno free culture
high yields
e&l
process validation strategy
regulatory considerations
risk-based approach
technology transfer
cdmo
end to end
capsid protein
cqa
critical quality attributes
orthogonal method
orthogonal methods
technically unavoidable particle profiles
emprove® chemicals
emprove®
lsm
laser scanning microscopy
optical coherence technology
coating formulation development
oct
particle designed pva
coating process
coating
dashboard
data center
saas
software and automation
software development
software
closed processing
single-use tff
hc agnostic
hcp id
hcp
host cell protein impurities
biotherapy purity
host cell proteins
powder feeding
cm
electrostatic charge
crazy powder
(qc) test methods
mycoplasma
methods for sterility
quality control testing
test methods
compen-dial
proteins
peptides
injectables
sterility assurance
roller compaction
granulated material
raw material handling
dry granulation
caking and clumping
manufacturing efficiency
flocculation
protein a resin
scale-up development
virusexpress™ lentiviral production platform
mobius® single-use bioreactors
templated manufacturing process
suspension-based lentivirus production
bioreactor process
scalable upstream bioreactor process
scalability
lentiviral vector production
filament-based
hot melt extrusion process
pharmaceutical industry
pharmaceutical manufacturing
pharmaceutical dosage
pharmaceutical dosage forms
additive manufacturing
formulation development
perfusion technologies
perfusate
viral contaminant
cell banks
bio4c™ processpad data management software
biocontinuum™
bioprocess lifecycle management
process verification (cpv)
bio4c™ processpad
advanced analytics
smart data management
bio4c™
chromatography resin
monoclonal antibody purification
preparative chromatography
analytical chromatography
oxygen mass transfer
clinical scale
bench scale
bioreactors
high-viscosity tff
reverse osmosis
nanofiltration
fed-batch production
fda regulatory guidance
rcl testing
lentivirus testing
biosafety and characterization testing
upstream
foot and mouth (fmd) disease
biopharma
media filtration
barrier filters
mrna therapies
mrna production process
mrna delivery systems
therapeutics
single-use manufaturing
e. coli
recombinant growth factor
antibody drug conjugates
technically unavoidable particles
chemicals
pharmaceuticals
coriolis
recombinant
npi
pharmaceutical-grade sucrose
intein
affinity capture
discovery
continuous virus inactivation
intensified capture
next-generation bioprocessing
filter plugging
bulk filtration
downstream unit operations
scalable purification
data driven
biopharma manufacturing
compressibility
bulk density
flow
continuous tablet manufacturing
microbial contamination
excipients in china
excipient regulations
biosolve
cost of goods sold
process model
viral vectors
sars-cov2
mers
ebola
h1n1 influenza
corona virus
outbreak
global health challenges
pandemic
vaccine production
fouling model
vmax method
pmax method
bpsa
perfusion bioreactor
single-pass tangential flow filtration
sedimentation velocity analytical ultracentrifugat
virus assay
cell assay
virology
viral genome
viral capsids
auc assay
tableting
sustained release
active pharmaceutical ingredients
fast track approach
• data visualization
• cpv
• continued process verification
• laboratory information management system (lims)
• manufacturing execution system (mes)
• enterprise resource planning (erp)
• biopharmaceutical processes
• data management
• next-generation bioprocessing
• software analytics
• software and automation
• integrated solutions
hdx mass spectrometry
peg linkers
spectroscopy
product recovery
acoustic cell processing
cell therapy manufacturing
blazar
viral screening
bioinformatics
next generation sequencing
rapid molecular method
biologic therapy
biotherapeutic
lai
long-acting injectable
targeted drug delivery
rna vaccines
rna therapeutics
rna delivery
novel cell models
immunotherapy research
immunotherapy
immunotherapeutics
genome editing technology
generating tumor-associated antigen panels
engineered custom cell line
engineered cell line
antigen cell lines
batch release
closed sampling
perfused seed train
integrated systems
perfusion filter
n-1
novel perfusion
cryopreservation
analytical development
titer
mitigating risks
big data
facility intensification
buffer delivery
process monitoring
regulatory compliant
continued process verification
cpv
purification template
horizon2020
disposable technology
continuous chromatography
biosimilar mab
virus spiking
api registration
formula
single-use connectors
single-use assemblies
integrity testers
cell & gene therapy (cgt) services
biopharm ingredients
biologics manufacturing
post approval changes
process impurities
assays
biotherapy
pei
eu commision
falsified medicine directive
chinese regulation
regulations
intensified mab purification
preclinical stage
clone selection
biopharma training
apac
emerging markets
efficiency in media preparation
compaction of cell culture media and single chemic
buffer concentrates
footprint saving buffer management
cell lines
cell culture media and supplements
industry 4.0
multi-use systems hardware
platform assay
platform manufacturing
solubility
slc
scale-up
gmp cell banking
activated polyethylene glycols
polyethylene glycols
liphophilic payload
pk/pd
monodisperse
linkers
clinical trial
kla
process scalability
bioprocess international
map/hap
supply robustness
forecast
collaborative forecasting
phenylketonuria
gmp manufacturing
glycosylation
n-glycan profiling of monoclonal antibodies
potency
single-pass tengential flow filtration
single-pass
prefilter
bioprocesing
intravenous immunoglobulin
ivig purification
process optimization
drug approval
accelerate product certification
pasteurization
viral risk mitigation
htst
small molecule series
smallmoleculeseries
pla/plga polymersmall molecules
optimum polymer technologyformulation technologies
synbiosys® multi-block polymer introductionparente
polymer based drug delivery systems
polymer based parenteral controlled-release drug d
biodevelopment
synthetic lipids
testing considerations
microcarrier
philipp buehle
2d data matrix barcode
2d barcode
barcode
drug manufacturer
raw materials supplier
digital innovation
biotech
events
science
douglas bowman
appropriate quality
bioreliance services
martin wisher
european pharmacopoeia
fda
agent contamination
virus seed
business development
zfn
risk
solvent
funding
corporate funding
startup
venture capital
alison armstrong
final fill vial
viral contamincation
viral risk
process sampling
novaseptum
genotoxicity
serum free media
fetal bovine serum
bioassays
small-molecule api
drypour
mobius
adventitious virus
ex-cell advanced
ucoe
expression vectors
shear protection
bioprocess performance loss
lot-to-lot variation
poloxamer 188
pluronic-f68
media prep
Ver más